 |
recombinant human interleukin-12 |
|---|---|
| Trade Name | Hemamax |
| Orphan Indication | Acute Radiation Syndrome Acute radiation syndrome |
| USA Market Approval | USA |
| USA Designation Date | 2016-08-22 00:00:00 |
| Sponsor | Neumedicines, Inc.;133 Altadena Drive, Suite 133;Pasadena, California, 91107 |
Learn more about: